# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) has completed the previously announced acquisition of a 6,500-square-foot, purp...
Benchmark analyst Mike Hickey reiterates Medicine Man Technologies (OTC:SHWZ) with a Buy and maintains $2.5 price target.
Medicine Man Technologies, Inc., operating as Schwazze (OTC: SHWZ), announced its financial results for the first quarter ended...
Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate...
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-st...
A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicatin...